Patients with Metastatic Colorectal Cancer and RAS (KRAS or NRAS) Gene Mutation Spared Treatment with Anti-epidermal Growth Factor Receptor (EGFR) Monoclonal Antibodies - ICD-10-CM Quality Payment Program Measure
| Quality Measure | Description | High Priority | Submission Methods |
|---|---|---|---|
| Patients with Metastatic Colorectal Cancer and RAS (KRAS or NRAS) Gene Mutation Spared Treatment with Anti-epidermal Growth Factor Receptor (EGFR) Monoclonal Antibodies | Percentage of adult patients (aged 18 or over) with metastatic colorectal cancer and RAS (KRAS or NRAS) gene mutation spared treatment with anti-EGFR monoclonal antibodies. | YES | Registry |
Linked ICD-10 Codes
The following ICD-10-CM codes are linked to the quality measure patients with metastatic colorectal cancer and ras (kras or nras) gene mutation spared treatment with anti-epidermal growth factor receptor (egfr) monoclonal antibodies when used as part of a patient's medical record. This Quality Measure is part of Medicare's Quality Payment Program (QPP).
| ICD Code | Description | Category |
|---|